XML 46 R51.htm IDEA: XBRL DOCUMENT v2.3.0.15
Intangible Assets (Narrative) (Details) (USD $)
3 Months Ended9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Sep. 30, 2010
Dec. 31, 2010
Dec. 31, 2010
CGI Pharmaceuticals [Member]
IPR&D [Member]
Sep. 30, 2011
IPR&D [Member]
Dec. 31, 2010
IPR&D [Member]
Mar. 31, 2011
IPR&D [Member]
CV Therapeutics [Member]
Dec. 31, 2010
IPR&D [Member]
CV Therapeutics [Member]
Acquired Finite-Lived Intangible Assets [Line Items]          
Amortization expense$ 17,400,000$ 14,900,000$ 52,200,000$ 44,900,000      
Indefinite-lived intangible assets292,830,000 292,830,000 29,530,00026,600,000292,800,00029,500,000 2,900,000
Finite lived intangible assets$ 814,071,000 $ 814,071,000 $ 863,393,000   $ 2,900,000